Acetylation is thought to be a key event for p53 activation. We demonstrate that p14ARF-induced senescence of human mammary epithelial cells (MEC) is associated with p53 acetylation and requires hAda3, a component of histone acetyltransferase complexes and a p53 transcriptional coactivator. Expression of the N-terminal domain of hAda3 that binds p53 but not p300 blocked p14ARF-induced p53 acetylation and protected MECs from senescence. Consistent with these findings, the human papillomavirus 16 E6 mutant Y54D, which selectively targets hAda3 but not p53 for degradation and protects MECs from p14ARF-induced senescence, inhibited p53 acetylation. In H1299 cells, hAda3 overexpression increased p300-mediated p53 acetylation, which conversely decreased following small interfering RNA (siRNA) knockdown of hAda3. Moreover, depletion of hAda3 by siRNA inhibited endogenous p53 acetylation and accumulation of p21cip1 in response to ectopic p14ARF. These studies reveal that, in addition to its known ability to inhibit Mdm2-mediated p53 degradation, p14ARF signals through hAda3 to stimulate p53 acetylation and the induction of cell senescence.
Introduction
Disparate stimuli lead to p53 activation by protein stabilization and complex post-translational modifications, of which p53 phosphorylation and acetylation have been best studied (Appella, 2001) . Activated p53 can induce growth arrest, apoptosis or senescence by activation of an array of p53 target genes such as p21cip1 and Bax (Vousden, 2002) . The p53 protein is inactivated by MDM2, which binds p53, inhibits its transcriptional activity and targets p53 for ubiquitindependent proteasomal degradation (Michael and Oren, 2003) .
Genotoxic stress stimulates p53 phosphorylation and acetylation, but only a few studies address alterations in p53 status induced by ply alternative reading frame (ARF). The ARF protein (p14ARF in human, p19ARF in mouse) is encoded by an alternative reading frame of the Ink4a-ARF locus. Ectopic expression of ARF induces growth arrest or senescence of human and mouse cells through a p53-and p21-dependent pathway. p53 acetylation increased during replicative and rasinduced senescence in human and murine cells (Pearson et al., 2000; Pedeux et al., 2005) . While ARF is known to induce cell senescence, evidence for a role of ARF signaling on p53 acetylation is indirect. Murine p19ARF reversed HDM2 inhibition of human p53 acetylation mediated by p300, a histone acetyltransferase (HAT) (Ito et al., 2001) . It is not known whether human p14ARF can induce p53 acetylation in the context of endogenous HATs.
Yeast ADA3 (alteration/deficiency in activation) is a transcriptional adapter protein and an essential component of HAT complexes required for nucleosomal histone acetylation (Grant et al., 1997; Balasubramanian et al., 2002) . Human Ada3 (hAda3) was identified in several HAT complexes (Ogryzko et al., 1998) . hAda3 is a 432 amino acid (aa) protein; the N-terminal domain of hAda3 (aa 1-214) binds p53 while the C-terminal domain (aa 215-432) interacts with components of the HAT complex (Wang et al., 2001 ). hAda3 appears to be required for p53-mediated transcriptional activation and apoptosis (Wang et al., 2001; Kumar et al., 2002) .
The human papillomavirus (HPV) type 16 oncogene E6 efficiently immortalizes primary human mammary epithelial cells (MEC) (Band et al., 1990) . HPV 16 E6 has multiple activities and at least two appear to be relevant for immortalization: inactivation of the p53 protein (Liu et al., 1999b) and induction of telomerase (Klingelhutz et al., 1996) . Interestingly, a subset of immortalizing E6 mutants that do not degrade p53 still target the hAda3 protein for degradation and inhibit p53-mediated transactivation (Kumar et al., 2002) . This suggests that inhibition of hAda3 may constitute a distinct mechanism by which E6 can block p53 functions without degrading the p53 protein.
We previously reported that ectopic expression of p14ARF induced p53-dependent senescence of hTERTimmortalized MEC (hTERT-MEC). In contrast, MEC immortalized by the E6 mutant Y54D (E6 Y54D ), which is unable to degrade p53, displayed an attenuated p14ARF-induced senescence response and continued to proliferate (Shamanin and Androphy, 2004) . Since E6 Y54D retains ability to downregulate the hAda3 protein, we suspected that hAda3 serves to modulate p53 activation signals in response to p14ARF. Here we demonstrate that p14ARF-induced senescence stimulates p53 acetylation, and this program is regulated in part by hAda3.
Results
hAda3 regulates p300-mediated p53 acetylation The hAda3 protein complexes with both p53 and p300 and enhances p53 transcriptional activity (Wang et al., 2001; Kumar et al., 2002) . We confirmed hAda3 binding to p53 by coimmunoprecipitation of Flag-hAda3 and p53 following transfection into p53 null human H1299 cells. While chemical cross-linking was previously required to detect their association (Wang et al., 2001 ), this step was not necessary in our experiments (Supplementary Information Figure 1 ). Interestingly, inclusion of HDM2 did not reduce Flag-hAda3 coimmunoprecipitation with p53.
In agreement with earlier studies, p300 induced dosedependent acetylation of p53 expressed in H1299 cells (data not shown). At low levels of transfected p300, hAda3 enhanced p53 acetylation as detected by panacetylated p53 (Luo et al., 2001 ) and acetylated Lys-382 p53 (Ac-K382-p53) antibodies ( Figure 1a , lanes 2-5). The Ac-K382-p53 antibody produced stronger signals and was subsequently used for detection of acetylation of endogenous p53.
The yeast ADA3 protein does not possess intrinsic HAT catalytic activity (Balasubramanian et al., 2002) , so we anticipated that hAda3 itself would not induce p53 acetylation. As predicted, overexpression of hAda3 without exogenous p300 did not enhance p53 acetylation ( Figure 1b , lanes 2 and 3), indicating that under conditions used in the experiments, endogenous HAT levels were limiting. In comparison to Flag-hAda3, expression of truncated N-hAda3 did not enhance p53 acetylation (Figure 1b , lanes 2 and 5). We subsequently tested the consequences of hAda3 depletion by transfecting small interfering RNA (siRNA) directed to hAda3 along with p300 and p53 into H1299 cells. Downregulation of the endogenous hAda3 mRNA was confirmed by reverse transcription-polymerase chain reaction (RT-PCR) (Figure 1c, lane 3) . Importantly, knockdown of hAda3 reduced p53 acetylation as determined with both the pan-acetylated and Ac-K382-p53 antibodies ( Figure 1c, lanes 2 and 3) .
HPV 16 E6 and a subset of MEC immortalizationcompetent 16 E6 mutants destabilize the hAda3 protein (Kumar et al., 2002) . We previously characterized mutant, E6
Y54D
, which immortalizes MECs and does not degrade p53 in vivo (Shamanin and Androphy, 2004) . To test whether E6 Y54D targets hAda3, we transiently expressed Flag-hAda3, p53 and E6 Y54D in H1299 cells (Figure 2a) . We included for reference wildtype 16 E6 and the p53 degradation-defective 16 E6 mutant F2V that was previously reported to induce hAda3 degradation (Kumar et al., 2002) . As expected, 16 E6 decreased both p53 and Flag-hAda3 levels. While E6 Y54D did not reduce levels of p53, it dramatically decreased Flag-hAda3 protein comparable to levels observed with wild-type E6. Moreover, expression of E6 Y54D inhibited p300-induced p53 acetylation in the absence of p53 degradation (Figure 2b lanes 2, 3) . Taken together, these experiments describe the role of hAda3 as a cofactor for p53 acetylation induced by p300 and indicate that HPV16 E6 may inhibit p53 acetylation, at least partially, by targeting hAda3.
Truncated hAda3 protects immortal hTERT-MEC from p14ARF-induced senescence Three lines of evidence suggest that hAda3 functions in the p14ARF-p53 pathway: (1) hAda3 enhances p53 acetylation and transactivation (2) E6 Y54D targets hAda3 and inhibits p14ARF-p53 signaling and (3) siRNA to hAda3 inhibits acetylation of p300-mediated acetylation Figure 1 p53 acetylation mediated by p300 is dependent on hAda3. (a) hAda3 enhances acetylation of p53 in H1299 cells. H1299 cells were transfected with 2 mg of p53, 400 ng of HA-p300, 0.5 mg of enhanced green fluorescent protein DNA and increasing amounts (1, 2 and 4 mg) of Flag-hAda3. Cells were harvested 24 h after transfection and lysates analysed by Western blot. Note that levels of total p53 remained constant while both pan-acetylated (Pan-Ac-p53) and acetylated Lys-382 p53 (Ac-K382-p53) levels increased with increasing amounts of hAda3. Ratio of Ac-K382-p53 to total p53 was quantified and average of three independent experiments is shown. (b) hAda3 does not acetylate p53 without p300 and truncated N-hAda3 does not enhance p53 acetylation. H1299 cells were transfected with 2 mg of p53, 400 ng HA-p300 and 4 mg of Flag-hAda3 or Flag-N-hAda3. Cells were harvested 24 h after transfection. (c) hAda3 siRNA inhibits p53 acetylation induced by p300. H1299 cells were transfected with 2 mg of p53, 100 ng of HA-p300 and 10 nM of oligo siRNA to hAda3 or GFP. Cells were harvested 48 h after transfection. Note that siRNA to hAda3 inhibited acetylation of p53 detected by both Pan-Ac-p53 and Ac-K382-p53 antibodies. siRNA to hAda3 efficiently decreased levels of hAda3 RNA while levels of GAPDH remained constant.
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-immortalized MEC (Y54D-MEC) (Shamanin and Androphy, 2004) . We attempted to select hTERT-MECs with reduced hAda3 levels using retroviral transduction of hAda3 shRNA. However, while the cells initially exhibited lowered hAda3 mRNA, this returned to baseline levels within the timeframe required for these experiments. We were also unable to perform transient RNAi knockdown of hAda3 in hTERT-MECs because these are poorly transfectable. Therefore, we used a different approach to selectively inactivate hAda3. Because transient overexpression of the N-terminal domain of hAda3 (N-hAda3) protected U2OS cells from UV-induced apoptosis (Wang et al., 2001) , we tested whether stable expression of N-hAda3 would protect hTERT-MEC from p14ARF-induced senescence.
Immortal hTERT-MEC were infected with pLXSNFlag-N-hAda3 retrovirus and pooled after selection with G418. Parental hTERT-MEC, hTERT-MEC with Flag-N-hAda3 (TNA-MEC) and hTERT-MEC expressing dominant-negative (dn) p53 R247W (T53-MEC) (Shamanin and Androphy, 2004) , all derived from the 76N strain, were infected with pWZL-hygro-p14ARF or empty retroviruses and selected with hygromycin. Cells were fixed and stained with crystal violet to assess cell morphology and growth (Figure 3a and b) . In agreement with our previous study (Shamanin and Androphy, 2004) , by day 7 postinfection hTERT-MEC displayed p14ARF-induced senescence. p14ARF-infected hTERT-MEC displayed the senescent morphology of large, vacuolated cells but did not manifest senescenceassociated b-galactosidase (SA-b-gal) (Shamanin and Androphy, 2004) , consistent with a recent report that SA-b-gal is not required for senescence (Lee et al., 2006) . In contrast, p14ARF did not induce growth arrest or the senescent morphology in T53-MECs. Interestingly, TNA-MEC infected with p14ARF showed a transient growth arrest initially manifested by large flat cells followed by outgrowth of smaller proliferating cells (Figure 3a, lower panel) . This was not due to selection of a resistant clone since multiple colonies of proliferating cells were distributed throughout the plate in repeated experiments. The morphological changes in MEC infected with p14ARF reflected their growth rate (Figure 3b) . The proliferative rate of TNA-MEC was greater than hTERT-MEC and similar to the response of MEC expressing E6
Y54D (Shamanin and Androphy, 2004) . By day 9 postinfection, the N-hAda3 or E6 Y54D expressing MECs recovered from p14ARF-induced growth arrest and exhibited normal proliferation. In contrast to hTERT-MEC and TNA-MECs, growth of T53-MECs was not affected by p14ARF and these saturated the plate by day 11 postinfection.
Flow cytometric analysis of PI-stained hTERT-MEC at day 7 postinfection with p14ARF showed accumulation of cells with G1 and sub-G1 DNA content and decreased amount of cells in S phase (Figure 3c ). This implied activation of the G1/S checkpoint and apoptosis presumably by a p53-dependent mechanism, as there were no changes in the flow cytometry profile of p14ARF-infected T53-MECs. TNA-MECs infected with p14ARF also arrested in G1, suggesting an intact G1/S checkpoint. In contrast to hTERT-MEC, TNA-MEC showed only a slight increase in the sub-G1 population, suggesting a compromised apoptotic response.
p14ARF-induced senescence is associated with p53 acetylation and accumulation of p21cip1 To understand the mechanism of N-hAda3-mediated inhibition of the response to p14ARF in MECs, we evaluated p53 K382 acetylation and the induction of p21cip1. In senescent hTERT-MECs, ectopic p14ARF induced Ac-K382-p53 and accumulation of both p53 and p21cip1 proteins (Figure 4a, lanes 1-4; Figure 4c , lanes 1 and 2) and p21cip1 RNA (Figure 4b) , indicating p53 activation.
Strikingly, expression of Flag-N-hAda3 in TNAMECs completely blocked acetylation of p53 K382 and accumulation of total p53 in response to p14ARF (Figure 4a , lanes 5-8; Figure 4c, lanes 3 and 4) . TNAMECs displayed increased p21cip1 mRNA (Figure 4b ) and protein levels (Figure 4a , lanes 5 and 6), in agreement with their phenotype indicated by flow cytometry (Figure 3c ). However, levels of the p21cip1 induction were reduced in comparison to hTERT-MEC, and by day 12, when TNA-MECs were actively dividing, the levels of p21cip1 had returned to baseline (Figure 4a , lanes 7 and 8). There was no induction of p21cip1 mRNA or protein in T53-MECs (data not shown), indicating that p21cip1 induction is p53 dependent. We noticed that levels of Flag-N-hAda3 protein decreased in p14ARF infected MECs (Figure 4a, lanes 5-8) . There Y54D did not decrease levels of total p53 but reduced levels of hAda3. GFP and actin were used as transfection and loading controls, respectively. Lane C-control pLXSN DNA (3 mg). (b) HPV16 E6 Y54D decreases acetylation of p53. Western blot of H1299 cells transfected with 1 mg of p53, 400 ng of HAp300, 1 mg of Flag-hAda3 and 3 mg of HPV16 E6 Y54D DNA. Cells were harvested 48 h after transfection. Note that E6
Y54D downregulated levels of Flag-hAda3 and inhibited K382 acetylation of p53. Actin was used as a loading control.
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Importantly, TNA-MECs that recovered from p14ARF-mediated growth inhibition continue to express p14ARF and p53 (Figure 4a, lane 8) . To prove that p14ARF expression is maintained in proliferating TNA-MECs, we detected incorporation of BrdU and expression of p14ARF by immunofluorescence at day 12 postinfection (Supplementary Information Figure 2 ). These results indicate that TNA-MECs acquired resistance to p14ARF-induced p53 activation by abrogating p53 acetylation and reducing accumulation of p21cip1.
Depletion of hAda3 by siRNA inhibits acetylation of p53 and accumulation of p21cip1 induced by p14ARF Experiments in hTERT-MEC clearly showed that truncated N-hAda3 inhibited accumulation of Ac-K382-p53 and p21cip1 proteins and blocked senescence induced by p14ARF. To evaluate the role of endogenous hAda3 in p14ARF signaling, we used an RNAi approach in U2OS cells, a p14ARF-negative osteosarcoma cell line that expresses wild-type p53. We depleted endogenous hAda3 by means of siRNA and then evaluated activation of endogenous p53 and induction of 21cip1 after transfection of p14ARF ( Figure 5 ). We used green fluorescent protein (GFP) siRNA as a Retrovirus infection cells were split into D-media containing hygromycin after 48 h. At 5, 7, 9 and 11 days post-infection cells were fixed, stained with crystal violet, optical density was measured and used to determine growth curves (Serrano et al., 1997) . Experiments were performed three times in duplicates. In contrast to hTERT-MECs, which remained arrested at all time points, hTERT-MEC expressing Flag-N-hAda3 recovered from p14ARF-induced growth arrest by day 9 post-infection. hTERT-MEC expressing dn-p53 are resistant to p14ARF and saturated plate before day 11 post-infection. Figure 5d , lanes 1 and 2). Remarkably, siRNA depletion of hAda3 inhibited accumulation of Ac-K382-p53 (Figure 5d , lanes 3 and 4) and total p53 and p21cip1 proteins (Figure 5a , lanes 3 and 4) and reduced the induction of p21cip1 mRNA (Figure 5c ). These findings demonstrate that p14ARF acts through hAda3 to induce acetylation and activation of p53.
Discussion
We report that in two different cell types ectopic p14ARF induces p53 acetylation. Importantly, p53 acetylation was detected in the context of endogenous HAT and endogenous p53 and without use of trichostatin A, a histone deacetylase inhibitor that is commonly added to detect p53 acetylation (Sakaguchi et al., 1998) . hAda3 is component of several HAT complexes, including p300/CBP and PCAF, which are recognized p53 acetylases (Gu and Roeder, 1997; Ogryzko et al., 1998; Sakaguchi et al., 1998; Liu et al., 1999a) . We demonstrate that p53 acetylation induced by p300 or p14ARF requires hAda3. The p53 degradation-defective mutant HPV16 E6 Y54D targeted hAda3 for degradation and inhibited Depletion of hAda3 by siRNA inhibits p53 activation induced by p14ARF in U2OS cells. U2OS cells were transfected with 10 nM hAda3 siRNA and 1 mg of p14ARF expression plasmid. GFP siRNA and empty vector DNA (V) were used as controls. Cells were harvested 48 h after p14ARF transfection. (a) Cell lysates were analysed by Western blot with antibodies to p14ARF, Ac-K382-p53, total p53 (DO-1) and p21cip1. Actin was used as a loading control. Expression of endogenous hAda3 mRNA was detected by RT-PCR. PCR reactions spiked with pcDNA3-hAda3 DNA (5, 50 and 500 fg) were used as positive standards. RT-PCR for GAPDH was used as a loading control. In contrast to GFP siRNA, siRNA to hAda3 blocked induction of Ac-K382-p53, total p53 and p21cip1 by p14ARF (compare lanes 2 and 4). hAda3 regulates p14ARF-induced senescence P Sekaric et al p300-mediated p53 acetylation. Using a different approach, it was reported that HPV18 E6 blocked p53 acetylation independent of its degradation (Thomas and Chiang, 2005) . E6 inhibition of p300 has been described (Patel et al., 1999; Zimmermann et al., 1999) . We propose that E6 targets hAda3, thereby blocking p300-mediated acetylation and activation of p53 and preventing cell senescence.
Our results suggest that in addition to its ability to induce p53 ubiquitination, degradation of hAda3 may represent another mechanism for HPV 16 E6-mediated inhibition of p53 functions. However, the 'low-risk' HPV11 E6, which does not immortalize MECs, reportedly did not bind hAda3 (Kumar et al., 2002) but was able to inhibit p53 transcriptional activity (Thomas and Chiang, 2005) . Further investigations of the activities of low-risk genital as well as benign and oncogenic cutaneous HPVs in abrogating p14ARF induced p53 acetylation and the relationships to hAda3 are warranted.
Both truncated N-hAda3 and the HPV16 E6 mutant that degrades hAda3 but not p53 attenuated p14ARF-induced senescence in cells that maintain expression of p14ARF and p53. The molecular mechanism involved in attenuation of senescence appears to be inhibition of p53 acetylation and inhibition of accumulation of p21cip1. This interpretation agrees with other studies that showed overexpression of p21cip1 induces senescence in human fibroblasts (Fang et al., 1999) , while p21cip1 null human fibroblasts are resistant to p14ARF-induced senescence (Wei et al., 2001) .
The detailed mechanism how hAda3 contributes to p21cip1 stabilization requires further investigation. While inhibition of p53 acetylation represents a molecular mechanism to decrease p53 activation, our data and other studies (Espinosa and Emerson, 2001) suggest that p53 acetylation is not absolutely required for p53-dependent transcription of p21cip1. p21cip1 is regulated by complex p53-dependent and p53-independent mechanisms. Interestingly, MDM2 targets p21cip1 for degradation and this reaction is inhibited by p19ARF (Jin et al., 2003; Zhang et al., 2004) . Since both p53 and MDM2 are acetylated by p300, and acetylation inhibits MDM2 ubiquitin ligase function , the hAda3 may affect p21cip1 levels by activating p53-dependent p21cip1 transcription and inhibiting MDM2-dependent p21cip1 protein degradation.
In addition to senescence and growth arrest, ectopic p14ARF expression resulted in accumulation of MECs with sub-G1 DNA content, suggesting apoptosis. While overexpression of ARF can induce p53-independent apoptosis (Sherr, 2006) , in our study using human cells, both the sub-G1 and senescence responses to p14ARF were hAda3 dependent.
Our model (Figure 6 ) depicts the putative role of hAda3 in p14ARF signaling. p14ARF expression inhibits HDM2 and activates p300 or other HAT(s), thus causing p53 stabilization and acetylation. hAda3 is required for p53 acetylation and induction of persistent elevated levels of p21cip1. High-risk HPV E6 targets p53 and hAda3 for degradation and by both means abrogates p14ARF signaling to p53. This model implies that p53 acetylation is required to establish senescence in contrast to a reversible growth arrest. We found decreased Ac-K382-p53 levels in senescent hTERT-MEC by day 12 post-p14ARF infection, suggesting that after senescence is established persistent p53 acetylation is not required. It is in agreement with observation that cells with inducible p53 exhibit irreversible growth arrest after p53 expression ceased (Sugrue et al., 1997) .
In summary, we used three 'loss-of-function' approaches to validate the role of hAda3 in p53 acetylation and cell senescence: expression of truncated N-hAda3 that does not bind p300; the high-risk papillomavirus E6 mutant Y54D that targets hAda3 but not p53 for degradation and hAda3 RNAi. Our data show that p53 acetylation is associated with p14ARF-induced senescence and is regulated by hAda3.
Materials and methods
Plasmids, cells, reagents and methods for RNA extraction, RT-PCR, real-time RT-PCR and flow cytometry are described in Supplementary Information.
Protein detection
Western blots were performed as described (Shamanin and Androphy, 2004) .
Acetylation of exogenous p53 was tested in transiently transfected H1299 cells. After 24 h cells were harvested and lysed in Flag buffer (Luo et al., 2001) supplemented with complete protease inhibitor (Roche, Nutley, NJ, USA), 10 mM trichostatin A and 5 mM nicotinamide (Sigma Aldrich, St Louis, MO, USA). Cell lysates containing 50 mg protein were separated by sodium dodecyl sulfate-polyacrylamide gel Figure 6 Model of hAda3 role in p14ARF-p53 signaling. p14ARF inhibits HDM2. HDM2 binds and induces p53 degradation and blocks p300 HAT activity. p14ARF causes release of p300 from HDM2 inhibition. hAda3 binds p300 and p53 and is necessary for HAT-mediated p53 acetylation in response to p14ARF. HPV16 E6 in complex with the ubiquitin ligase E6AP induces degradation of p53 and hAda3 thus blocking p14ARF-mediated activation of the p53 pathway.
hAda3 regulates p14ARF-induced senescence P Sekaric et al electrophoresis for Western blot with antibody to panacetylated p53 (Luo et al., 2001) . To detect acetylation of endogenous p53, lysates were prepared as described (Shamanin and Androphy, 2004) and 30 mg of total protein was tested by Western blot with antibody to Ac-K382-p53.
RNA interference
Depletion of endogenous hAda3 in U2OS cells was carried out using two sequential transfections. A total of 10 nM hAda3 siRNA or GFP siRNA was transfected into U2OS cells using Lipofectamine2000 (Invitrogen, Carlsbad, CA, USA). The transfection was repeated after 24 h with hAda3 or GFP siRNA and pWZH-Hygro-p14ARF DNA. Cells were harvested 48 h after second transfection. For H1299 cells, 10 nM hAda3 or GFP siRNA duplex was cotransfected with 100 ng of p300 and 1 mg p53 DNA. Cells were harvested 48 h after transfection.
